DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Preeclampsia & Fetal Growth Restriction
    • Acute Ischemic Stroke
  • Clinical Trials
    • Overview
    • Preeclampsia & Fetal Growth Restriction
    • Acute Ischemic Stroke
  • ReMEDy2 Trial
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Media
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Media

DM199 shows promise in phase 2 trial for treating preeclampsia
Jul 17, 2025

Contemporary OBGYN

DM199 shows promise in phase 2 trial for treating preeclampsia

RSS
  • Previous
  • 1
  • 2
© 2026 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap